Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Oct 8, 2024
Date Accepted: Jun 23, 2025

The final, peer-reviewed published version of this preprint can be found here:

Acceptance, Drivers, and Barriers to Use of mHealth Apps to Improve Quality of Life in Female Patients Affected by Hypothyroidism: Cross-Sectional Study

Doll M, Chandrakumar R, Jahre LM, Skoda EM, Dinse H, Führer D, Lampropulou E, Teufel M, Bäuerle A

Acceptance, Drivers, and Barriers to Use of mHealth Apps to Improve Quality of Life in Female Patients Affected by Hypothyroidism: Cross-Sectional Study

JMIR Form Res 2025;9:e67317

DOI: 10.2196/67317

PMID: 40774332

PMCID: 12331366

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Acceptance, Drivers, and Barriers to use mHealth Applications to Improve Quality of Life in Female Patients Affected by Hypothyroidism: a Cross-sectional Study

  • Moritz Doll; 
  • Ranujan Chandrakumar; 
  • Lisa Maria Jahre; 
  • Eva-Maria Skoda; 
  • Hannah Dinse; 
  • Dagmar Führer; 
  • Eleni Lampropulou; 
  • Martin Teufel; 
  • Alexander Bäuerle

ABSTRACT

Background:

Hypothyroidism is a common chronic disease associated with lower quality of life, a trend that interventions delivered by mHealth applications could ameliorate.

Objective:

The objective of the present study was to assess acceptance, drivers, and barriers to use mHealth applications to improve quality of life in female patients affected by hypothyroidism.

Methods:

A survey-based, cross-sectional study, which included N = 318 female patients affected by hypothyroidism (assessed via self-report) was conducted between April 2023 and April 2024. Sociodemographic, health, and eHealth-related data were assessed. To determine acceptance and its drivers and barriers, an extended version of the Unified Theory of Acceptance and Use of Technology model was applied. Group comparisons and multiple hierarchical regression were conducted.

Results:

Acceptance of mHealth applications was high (M = 4.10, SD = 0.91), with 76.1% (n = 242) of the participants reporting high acceptance, 18.6% (n = 59) reporting moderate acceptance, and only 5.3% (n = 17) reporting low acceptance. Significant predictors of acceptance were Place of Residence: Medium-sized city (β = .34, p = .02) and small town or rural area (β = .28, p = .003), Fatigue (β = .54, p < .001), Internet anxiety (β = -.20, p = .002), and the UTAUT predictors Effort expectancy (β = .37, p < .001), Performance expectancy (β = .32, p < .001), and Social influence (β = .20, p < .001). The extended model explained 56.1% of variance in acceptance.

Conclusions:

The high level of acceptance of mHealth applications observed among females affected by hypothyroidism suggests that mHealth interventions can provide such patients with valuable support to manage the disease. Drivers and barriers should be addressed during the implementation of mHealth interventions Clinical Trial: N/A


 Citation

Please cite as:

Doll M, Chandrakumar R, Jahre LM, Skoda EM, Dinse H, Führer D, Lampropulou E, Teufel M, Bäuerle A

Acceptance, Drivers, and Barriers to Use of mHealth Apps to Improve Quality of Life in Female Patients Affected by Hypothyroidism: Cross-Sectional Study

JMIR Form Res 2025;9:e67317

DOI: 10.2196/67317

PMID: 40774332

PMCID: 12331366

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.